*New York-Presbyterian Hospital, Weill Cornell Medical Center †Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY ‡Bristol-Myers Squibb Children's Hospital, Robert Wood Johnson Medical Center, New Brunswick, NJ §Celiac Disease Center at Columbia University, New York, NY.
J Pediatr Gastroenterol Nutr. 2013 Oct;57(4):477-86. doi: 10.1097/MPG.0b013e31829b68a1.
Given the social constraints imposed by a gluten-free diet, it can be hypothesized that children with celiac disease (CD) living in the United States have a reduced health-related quality of life (HRQOL); however, there is no validated CD-specific HRQOL instrument for children living in the United States. The goals of this study were to develop and validate a CD-specific HRQOL instrument for children 8 to 18 years of age with CD and to report HRQOL in these children using both generic- and disease-specific instruments.
This was a prospective study using focus group methodology to develop a CD-specific HRQOL instrument that was then administered to children 8 to 18 years of age with CD living throughout the United States. Instrument validation methods included construct, convergent, and divergent validities.
Two instruments were developed: CD-specific pediatric HRQOL instrument (CDPQOL) 8 to 12 and CDPQOL 13 to 18. A total of 181 children with CD completed the CDPQOL as well as a comparator generic instrument. Exploratory factor analysis restructured the CDPQOL and reduced the total number of items. The CDPQOL showed a moderate agreement with the Psychosocial dimensions of the generic instrument confirming convergent validity and low-to-moderate agreement with the Physical Health Summary dimension of the generic instrument confirming divergent validity.
The CDPQOL, consisting of 13 to 17 questions, is a validated instrument for the measurement of HRQOL in children 8 to 18 years of age with CD living in the United States.
鉴于无麸质饮食带来的社会限制,可以假设美国的乳糜泻(CD)患儿的健康相关生活质量(HRQOL)降低;然而,对于居住在美国的儿童,尚无经过验证的专门针对 CD 的 HRQOL 工具。本研究的目的是为 8 至 18 岁 CD 患儿开发和验证一种特定于 CD 的 HRQOL 工具,并使用通用和特定于疾病的工具报告这些儿童的 HRQOL。
这是一项前瞻性研究,使用焦点小组方法开发一种特定于 CD 的 HRQOL 工具,然后在美国各地的 8 至 18 岁 CD 患儿中进行管理。仪器验证方法包括结构、收敛和发散效度。
开发了两种仪器:8 至 12 岁的 CD 特定儿科 HRQOL 仪器(CDPQOL)和 13 至 18 岁的 CDPQOL。共有 181 名 CD 患儿完成了 CDPQOL 和比较通用仪器。探索性因子分析重构了 CDPQOL,并减少了总项目数。CDPQOL 与通用仪器的心理社会维度中度一致,确认了收敛效度,与通用仪器的身体健康综合维度低度至中度一致,确认了发散效度。
由 13 至 17 个问题组成的 CDPQOL 是一种经过验证的工具,可用于测量居住在美国的 8 至 18 岁 CD 患儿的 HRQOL。